

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.37422044 |
| 2 | formation of translation preinitiation complex (GO:0001731) | 4.46972485 |
| 3 | proteasome assembly (GO:0043248) | 4.26702646 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 4.20525438 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.13320931 |
| 6 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.11958598 |
| 7 | purine nucleobase biosynthetic process (GO:0009113) | 4.09060646 |
| 8 | folic acid metabolic process (GO:0046655) | 4.05424575 |
| 9 | oxidative phosphorylation (GO:0006119) | 4.03155301 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 3.98326982 |
| 11 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.90472555 |
| 12 | regulation of translational fidelity (GO:0006450) | 3.88673009 |
| 13 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.88604454 |
| 14 | mitotic chromosome condensation (GO:0007076) | 3.87793015 |
| 15 | DNA strand elongation (GO:0022616) | 3.84923717 |
| 16 | mitotic sister chromatid segregation (GO:0000070) | 3.82650287 |
| 17 | tricarboxylic acid cycle (GO:0006099) | 3.81186597 |
| 18 | DNA replication initiation (GO:0006270) | 3.77196597 |
| 19 | protein maturation by protein folding (GO:0022417) | 3.71733582 |
| 20 | proline biosynthetic process (GO:0006561) | 3.69534258 |
| 21 | ribosome biogenesis (GO:0042254) | 3.61171916 |
| 22 | IMP biosynthetic process (GO:0006188) | 3.59929310 |
| 23 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.58752083 |
| 24 | ribosome assembly (GO:0042255) | 3.58166665 |
| 25 | nuclear pore complex assembly (GO:0051292) | 3.55952043 |
| 26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.53425553 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.52228916 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.44843931 |
| 29 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.44697701 |
| 30 | DNA unwinding involved in DNA replication (GO:0006268) | 3.44435406 |
| 31 | telomere maintenance via recombination (GO:0000722) | 3.41608781 |
| 32 | ribosomal small subunit assembly (GO:0000028) | 3.41167995 |
| 33 | sister chromatid segregation (GO:0000819) | 3.40368504 |
| 34 | glycine metabolic process (GO:0006544) | 3.39294600 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.39118376 |
| 36 | DNA replication checkpoint (GO:0000076) | 3.38260742 |
| 37 | ribosomal large subunit biogenesis (GO:0042273) | 3.36249494 |
| 38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.32365743 |
| 39 | establishment of viral latency (GO:0019043) | 3.30450428 |
| 40 | spliceosomal snRNP assembly (GO:0000387) | 3.30182358 |
| 41 | mitotic metaphase plate congression (GO:0007080) | 3.29065163 |
| 42 | serine family amino acid biosynthetic process (GO:0009070) | 3.28923153 |
| 43 | mitotic nuclear envelope disassembly (GO:0007077) | 3.27041459 |
| 44 | IMP metabolic process (GO:0046040) | 3.23089398 |
| 45 | mitotic recombination (GO:0006312) | 3.22596678 |
| 46 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.22183467 |
| 47 | nuclear pore organization (GO:0006999) | 3.21818350 |
| 48 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.21156380 |
| 49 | viral transcription (GO:0019083) | 3.17582705 |
| 50 | negative regulation of ligase activity (GO:0051352) | 3.16465867 |
| 51 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.16465867 |
| 52 | translational termination (GO:0006415) | 3.15971551 |
| 53 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.14789350 |
| 54 | translational elongation (GO:0006414) | 3.14739061 |
| 55 | L-serine metabolic process (GO:0006563) | 3.14045994 |
| 56 | lysine catabolic process (GO:0006554) | 3.13860614 |
| 57 | lysine metabolic process (GO:0006553) | 3.13860614 |
| 58 | translational initiation (GO:0006413) | 3.13757982 |
| 59 | NADH metabolic process (GO:0006734) | 3.12297666 |
| 60 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.12036287 |
| 61 | protein localization to kinetochore (GO:0034501) | 3.11657288 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 3.11018166 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.11018166 |
| 64 | protein targeting to mitochondrion (GO:0006626) | 3.09214158 |
| 65 | pseudouridine synthesis (GO:0001522) | 3.08229684 |
| 66 | amino acid salvage (GO:0043102) | 3.07764145 |
| 67 | L-methionine salvage (GO:0071267) | 3.07764145 |
| 68 | L-methionine biosynthetic process (GO:0071265) | 3.07764145 |
| 69 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.06812270 |
| 70 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.06804540 |
| 71 | transcription from mitochondrial promoter (GO:0006390) | 3.06097222 |
| 72 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.05157810 |
| 73 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.04637577 |
| 74 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.04637577 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.03631666 |
| 76 | rRNA modification (GO:0000154) | 2.99714901 |
| 77 | COPI coating of Golgi vesicle (GO:0048205) | 2.99643210 |
| 78 | Golgi transport vesicle coating (GO:0048200) | 2.99643210 |
| 79 | telomere maintenance via telomere lengthening (GO:0010833) | 2.98999849 |
| 80 | nuclear envelope disassembly (GO:0051081) | 2.98012864 |
| 81 | membrane disassembly (GO:0030397) | 2.98012864 |
| 82 | viral mRNA export from host cell nucleus (GO:0046784) | 2.97995805 |
| 83 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97988257 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97988257 |
| 85 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.97244689 |
| 86 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.96696714 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.96696714 |
| 88 | chromatin remodeling at centromere (GO:0031055) | 2.96193474 |
| 89 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.95992484 |
| 90 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.95992484 |
| 91 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.95992484 |
| 92 | rRNA processing (GO:0006364) | 2.94750153 |
| 93 | CENP-A containing nucleosome assembly (GO:0034080) | 2.94355063 |
| 94 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.93494127 |
| 95 | positive regulation of ligase activity (GO:0051351) | 2.93295997 |
| 96 | regulation of translational termination (GO:0006449) | 2.92631642 |
| 97 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.92607271 |
| 98 | protein complex localization (GO:0031503) | 2.92576366 |
| 99 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.91034004 |
| 100 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.90353436 |
| 101 | negative regulation of mRNA processing (GO:0050686) | 2.89864544 |
| 102 | base-excision repair (GO:0006284) | 2.88191533 |
| 103 | * translation (GO:0006412) | 2.83988331 |
| 104 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.83601104 |
| 105 | mitochondrial RNA metabolic process (GO:0000959) | 2.83438863 |
| 106 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.82314762 |
| 107 | rRNA metabolic process (GO:0016072) | 2.82268794 |
| 108 | metaphase plate congression (GO:0051310) | 2.80968785 |
| 109 | tRNA aminoacylation for protein translation (GO:0006418) | 2.80101940 |
| 110 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.80016371 |
| 111 | protein deneddylation (GO:0000338) | 2.78642543 |
| 112 | cullin deneddylation (GO:0010388) | 2.78615276 |
| 113 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.78460847 |
| 114 | DNA replication-independent nucleosome organization (GO:0034724) | 2.78460847 |
| 115 | cell cycle G1/S phase transition (GO:0044843) | 2.77650180 |
| 116 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.77650180 |
| 117 | regulation of mitochondrial translation (GO:0070129) | 2.77602371 |
| 118 | tRNA aminoacylation (GO:0043039) | 2.77338964 |
| 119 | amino acid activation (GO:0043038) | 2.77338964 |
| 120 | ribosomal small subunit biogenesis (GO:0042274) | 2.75774629 |
| 121 | cellular component biogenesis (GO:0044085) | 2.75363495 |
| 122 | sulfur amino acid biosynthetic process (GO:0000097) | 2.74634758 |
| 123 | protein localization to chromosome, centromeric region (GO:0071459) | 2.73765707 |
| 124 | methionine biosynthetic process (GO:0009086) | 2.71936188 |
| 125 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.71065909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.54259272 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.38139994 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.13514592 |
| 4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.20454116 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.04014008 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.03920285 |
| 7 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.95045609 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.93862029 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.84374280 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.80502403 |
| 11 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.70188931 |
| 12 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69182751 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68260941 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.66212296 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.48806309 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.47215197 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.37405664 |
| 18 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.33603108 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24487721 |
| 20 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22157827 |
| 21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10349106 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03586423 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00511654 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.99862132 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.93367882 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.90647061 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.89289074 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86936707 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83471115 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.82112840 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79882703 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.79294240 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75359859 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.70850662 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.69812301 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69455204 |
| 37 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.69320692 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.68321331 |
| 39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.67416996 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65857722 |
| 41 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.63094454 |
| 42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62155532 |
| 43 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59148486 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.57607835 |
| 45 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.55052445 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.52374068 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50691363 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48302582 |
| 49 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46762003 |
| 50 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46326313 |
| 51 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44359063 |
| 52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42404012 |
| 53 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38974056 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.38860917 |
| 55 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38464092 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37454949 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35885906 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35293397 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.30933804 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29489368 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29466985 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28415839 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28316357 |
| 64 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27190134 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24278145 |
| 66 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24276750 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21522069 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18310912 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17894350 |
| 70 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16130405 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16128897 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14693063 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12598214 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11132170 |
| 75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09957131 |
| 76 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09650235 |
| 77 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08336006 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07798136 |
| 79 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06987543 |
| 80 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05993035 |
| 81 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04932848 |
| 82 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04163816 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02988315 |
| 84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02904907 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02756136 |
| 86 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02462499 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00961966 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00897395 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99906404 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99891855 |
| 91 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97139902 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96294564 |
| 93 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.95714867 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94527044 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92707393 |
| 96 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92280982 |
| 97 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.92009521 |
| 98 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91932092 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91792767 |
| 100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90972649 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90387784 |
| 102 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89087453 |
| 103 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.88400590 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87809160 |
| 105 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.87666140 |
| 106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87660160 |
| 107 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.86958475 |
| 108 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.86368318 |
| 109 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85465125 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85259967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.71294009 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.20826991 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.81461853 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.57065195 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.37942271 |
| 6 | MP0003077_abnormal_cell_cycle | 3.06131415 |
| 7 | MP0003646_muscle_fatigue | 2.85350873 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.49652271 |
| 9 | MP0008058_abnormal_DNA_repair | 2.31277047 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.23658754 |
| 11 | MP0005360_urolithiasis | 2.23266047 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.19692349 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.17986477 |
| 14 | MP0009697_abnormal_copulation | 2.15799066 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.15567130 |
| 16 | MP0005451_abnormal_body_composition | 2.15333168 |
| 17 | MP0001730_embryonic_growth_arrest | 2.14945274 |
| 18 | MP0008057_abnormal_DNA_replication | 2.08236007 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.01566476 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 1.96776345 |
| 21 | MP0002269_muscular_atrophy | 1.83035417 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.82885981 |
| 23 | MP0005365_abnormal_bile_salt | 1.82485457 |
| 24 | MP0000749_muscle_degeneration | 1.82055028 |
| 25 | MP0010030_abnormal_orbit_morphology | 1.79189141 |
| 26 | MP0005330_cardiomyopathy | 1.78749161 |
| 27 | MP0003186_abnormal_redox_activity | 1.76967806 |
| 28 | MP0001661_extended_life_span | 1.76177538 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 1.75977290 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.74840603 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.70680212 |
| 32 | MP0009840_abnormal_foam_cell | 1.68969255 |
| 33 | MP0008260_abnormal_autophagy | 1.67191127 |
| 34 | MP0000350_abnormal_cell_proliferation | 1.60258984 |
| 35 | MP0003786_premature_aging | 1.59325423 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59076511 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.58746718 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.51647044 |
| 39 | MP0005501_abnormal_skin_physiology | 1.45110197 |
| 40 | MP0003984_embryonic_growth_retardation | 1.44098016 |
| 41 | MP0005332_abnormal_amino_acid | 1.43774189 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.43280018 |
| 43 | MP0005380_embryogenesis_phenotype | 1.43280018 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.43018455 |
| 45 | MP0000751_myopathy | 1.42879751 |
| 46 | MP0001697_abnormal_embryo_size | 1.42724112 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.42601046 |
| 48 | MP0002080_prenatal_lethality | 1.40339558 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.40007078 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.36656764 |
| 51 | MP0005083_abnormal_biliary_tract | 1.35781249 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.35605237 |
| 53 | MP0003315_abnormal_perineum_morphology | 1.34403279 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.34164377 |
| 55 | MP0003941_abnormal_skin_development | 1.31665282 |
| 56 | MP0003123_paternal_imprinting | 1.30689978 |
| 57 | MP0005266_abnormal_metabolism | 1.30333222 |
| 58 | MP0000678_abnormal_parathyroid_gland | 1.30018254 |
| 59 | MP0000747_muscle_weakness | 1.24276143 |
| 60 | MP0003718_maternal_effect | 1.23293767 |
| 61 | MP0000358_abnormal_cell_content/ | 1.22009480 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 1.21828357 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.21531789 |
| 64 | MP0010630_abnormal_cardiac_muscle | 1.16393354 |
| 65 | MP0005670_abnormal_white_adipose | 1.16243011 |
| 66 | MP0000313_abnormal_cell_death | 1.12490479 |
| 67 | MP0004233_abnormal_muscle_weight | 1.09691032 |
| 68 | MP0001764_abnormal_homeostasis | 1.09059435 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.08161459 |
| 70 | MP0000490_abnormal_crypts_of | 1.06943031 |
| 71 | MP0001853_heart_inflammation | 1.06481174 |
| 72 | MP0002796_impaired_skin_barrier | 1.05662026 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.05129564 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.05129564 |
| 75 | MP0005408_hypopigmentation | 1.03522838 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 1.01928573 |
| 77 | MP0005385_cardiovascular_system_phenoty | 1.01928573 |
| 78 | MP0002106_abnormal_muscle_physiology | 1.00821223 |
| 79 | MP0002085_abnormal_embryonic_tissue | 1.00230688 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 0.99920254 |
| 81 | MP0000537_abnormal_urethra_morphology | 0.99431528 |
| 82 | MP0005384_cellular_phenotype | 0.96869450 |
| 83 | MP0002086_abnormal_extraembryonic_tissu | 0.96856788 |
| 84 | MP0004147_increased_porphyrin_level | 0.94569778 |
| 85 | MP0008775_abnormal_heart_ventricle | 0.94176809 |
| 86 | MP0006054_spinal_hemorrhage | 0.94081871 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.93634809 |
| 88 | MP0000609_abnormal_liver_physiology | 0.92337688 |
| 89 | MP0000759_abnormal_skeletal_muscle | 0.91964480 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.90967767 |
| 91 | MP0000598_abnormal_liver_morphology | 0.90877202 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.90002131 |
| 93 | MP0001727_abnormal_embryo_implantation | 0.89394130 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.87310059 |
| 95 | MP0001881_abnormal_mammary_gland | 0.86806246 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.86096708 |
| 97 | MP0002160_abnormal_reproductive_system | 0.85003405 |
| 98 | MP0010307_abnormal_tumor_latency | 0.83792469 |
| 99 | MP0005621_abnormal_cell_physiology | 0.83650850 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.83585319 |
| 101 | MP0002127_abnormal_cardiovascular_syste | 0.82829843 |
| 102 | MP0002084_abnormal_developmental_patter | 0.82279717 |
| 103 | MP0001666_abnormal_nutrient_absorption | 0.80561340 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.79909541 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.79690331 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79557023 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.79060034 |
| 108 | MP0004197_abnormal_fetal_growth/weight/ | 0.76440290 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.75717663 |
| 110 | MP0003191_abnormal_cellular_cholesterol | 0.75456764 |
| 111 | MP0002697_abnormal_eye_size | 0.74173637 |
| 112 | MP0001849_ear_inflammation | 0.72894861 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.72831854 |
| 114 | MP0009672_abnormal_birth_weight | 0.72621548 |
| 115 | MP0002210_abnormal_sex_determination | 0.72140584 |
| 116 | MP0002653_abnormal_ependyma_morphology | 0.71301082 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.70979223 |
| 118 | MP0001145_abnormal_male_reproductive | 0.70748344 |
| 119 | MP0005620_abnormal_muscle_contractility | 0.70314358 |
| 120 | MP0001929_abnormal_gametogenesis | 0.69548220 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69547880 |
| 122 | MP0001293_anophthalmia | 0.68662402 |
| 123 | MP0005369_muscle_phenotype | 0.68363419 |
| 124 | MP0002970_abnormal_white_adipose | 0.67795731 |
| 125 | MP0002722_abnormal_immune_system | 0.67174149 |
| 126 | MP0000858_altered_metastatic_potential | 0.66496921 |
| 127 | MP0002111_abnormal_tail_morphology | 0.66156985 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.65537958 |
| 129 | MP0002060_abnormal_skin_morphology | 0.65299382 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.62326227 |
| 131 | MP0004858_abnormal_nervous_system | 0.61075743 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.59490789 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.59309215 |
| 134 | MP0003385_abnormal_body_wall | 0.58871444 |
| 135 | MP0004272_abnormal_basement_membrane | 0.58734487 |
| 136 | MP0000653_abnormal_sex_gland | 0.56301068 |
| 137 | MP0002938_white_spotting | 0.55509360 |
| 138 | MP0002132_abnormal_respiratory_system | 0.55096729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 4.07212926 |
| 2 | Microvesicular hepatic steatosis (HP:0001414) | 3.80997901 |
| 3 | Hepatocellular necrosis (HP:0001404) | 3.76059681 |
| 4 | Cholecystitis (HP:0001082) | 3.74306753 |
| 5 | Abnormal gallbladder physiology (HP:0012438) | 3.74306753 |
| 6 | Rhabdomyolysis (HP:0003201) | 3.58869430 |
| 7 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.35058078 |
| 8 | Multiple enchondromatosis (HP:0005701) | 3.33411443 |
| 9 | Abnormality of alanine metabolism (HP:0010916) | 3.28975321 |
| 10 | Hyperalaninemia (HP:0003348) | 3.28975321 |
| 11 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.28975321 |
| 12 | Birth length less than 3rd percentile (HP:0003561) | 3.26242482 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.25394023 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.23415064 |
| 15 | Increased CSF lactate (HP:0002490) | 3.23231838 |
| 16 | Increased serum lactate (HP:0002151) | 3.23131438 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.19099952 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.19099952 |
| 19 | Myoglobinuria (HP:0002913) | 3.17330622 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.16611031 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.16526742 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.16526742 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.15569100 |
| 24 | Dicarboxylic aciduria (HP:0003215) | 3.15569100 |
| 25 | Hyperammonemia (HP:0001987) | 3.15012201 |
| 26 | Oral leukoplakia (HP:0002745) | 3.14117194 |
| 27 | Progressive muscle weakness (HP:0003323) | 3.11097755 |
| 28 | Acute encephalopathy (HP:0006846) | 3.07549764 |
| 29 | Mitochondrial inheritance (HP:0001427) | 3.07425748 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 3.07240662 |
| 31 | Lactic acidosis (HP:0003128) | 3.06684079 |
| 32 | Chromsome breakage (HP:0040012) | 3.04893843 |
| 33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.02816670 |
| 34 | Hyperglycinuria (HP:0003108) | 3.01901111 |
| 35 | Cerebral edema (HP:0002181) | 2.95056469 |
| 36 | Increased muscle lipid content (HP:0009058) | 2.90548362 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.90530292 |
| 38 | Nausea (HP:0002018) | 2.86123839 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.85444707 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.85444707 |
| 41 | Hyperglycinemia (HP:0002154) | 2.79653887 |
| 42 | Breast hypoplasia (HP:0003187) | 2.78206302 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.71871585 |
| 44 | Selective tooth agenesis (HP:0001592) | 2.71260520 |
| 45 | Hypoglycemic coma (HP:0001325) | 2.68688654 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.67966783 |
| 47 | Lethargy (HP:0001254) | 2.66461667 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.64567275 |
| 49 | Reticulocytopenia (HP:0001896) | 2.63229559 |
| 50 | Type I transferrin isoform profile (HP:0003642) | 2.63182519 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.60801581 |
| 52 | Abnormality of the anterior horn cell (HP:0006802) | 2.59215900 |
| 53 | Degeneration of anterior horn cells (HP:0002398) | 2.59215900 |
| 54 | CNS demyelination (HP:0007305) | 2.58837172 |
| 55 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53629483 |
| 56 | Abnormality of the umbilical cord (HP:0010881) | 2.52623066 |
| 57 | Carpal bone hypoplasia (HP:0001498) | 2.49428036 |
| 58 | Exercise intolerance (HP:0003546) | 2.49195781 |
| 59 | Ketosis (HP:0001946) | 2.45939666 |
| 60 | Respiratory failure (HP:0002878) | 2.45214208 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.43703853 |
| 62 | Microretrognathia (HP:0000308) | 2.41982449 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.41360809 |
| 64 | Ragged-red muscle fibers (HP:0003200) | 2.38028157 |
| 65 | Trismus (HP:0000211) | 2.37442552 |
| 66 | Macrocytic anemia (HP:0001972) | 2.36439863 |
| 67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34465978 |
| 68 | Rough bone trabeculation (HP:0100670) | 2.32174398 |
| 69 | Palpitations (HP:0001962) | 2.29598433 |
| 70 | Emotional lability (HP:0000712) | 2.29337715 |
| 71 | Proximal tubulopathy (HP:0000114) | 2.27724813 |
| 72 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.25251906 |
| 73 | Testicular atrophy (HP:0000029) | 2.24968996 |
| 74 | Cholelithiasis (HP:0001081) | 2.24336780 |
| 75 | Gout (HP:0001997) | 2.24212500 |
| 76 | Increased hepatocellular lipid droplets (HP:0006565) | 2.21074951 |
| 77 | Progressive external ophthalmoplegia (HP:0000590) | 2.20875507 |
| 78 | Hypobetalipoproteinemia (HP:0003563) | 2.19368129 |
| 79 | Abnormality of the preputium (HP:0100587) | 2.18703784 |
| 80 | Progressive macrocephaly (HP:0004481) | 2.15356332 |
| 81 | Megaloblastic anemia (HP:0001889) | 2.15243145 |
| 82 | Ketoacidosis (HP:0001993) | 2.14418875 |
| 83 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.14075680 |
| 84 | Single umbilical artery (HP:0001195) | 2.14075680 |
| 85 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.14075680 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.13192241 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.13192241 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 2.13192241 |
| 89 | Abnormal glycosylation (HP:0012345) | 2.13192241 |
| 90 | Myopathic facies (HP:0002058) | 2.13038054 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.10601834 |
| 92 | Ventricular tachycardia (HP:0004756) | 2.10354485 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.04718309 |
| 94 | Premature ovarian failure (HP:0008209) | 2.04385451 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04265276 |
| 96 | Pancytopenia (HP:0001876) | 2.03983872 |
| 97 | Patellar aplasia (HP:0006443) | 2.03813426 |
| 98 | Colon cancer (HP:0003003) | 2.02530689 |
| 99 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.01515082 |
| 100 | Angiofibromas (HP:0010615) | 2.01101663 |
| 101 | Adenoma sebaceum (HP:0009720) | 2.01101663 |
| 102 | Horseshoe kidney (HP:0000085) | 1.98978078 |
| 103 | Respiratory difficulties (HP:0002880) | 1.98222923 |
| 104 | Abnormality of reticulocytes (HP:0004312) | 1.97327268 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 1.96760021 |
| 106 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.95925140 |
| 107 | Increased nuchal translucency (HP:0010880) | 1.95171907 |
| 108 | Secondary amenorrhea (HP:0000869) | 1.93094421 |
| 109 | Neonatal death (HP:0003811) | 1.92944609 |
| 110 | Abnormality of methionine metabolism (HP:0010901) | 1.92140531 |
| 111 | Exercise-induced myalgia (HP:0003738) | 1.90734765 |
| 112 | Metabolic acidosis (HP:0001942) | 1.90711873 |
| 113 | Reticulocytosis (HP:0001923) | 1.89239925 |
| 114 | Meckel diverticulum (HP:0002245) | 1.88924664 |
| 115 | Ependymoma (HP:0002888) | 1.88804563 |
| 116 | Sudden death (HP:0001699) | 1.86994642 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86869151 |
| 118 | Spastic paraparesis (HP:0002313) | 1.86324339 |
| 119 | Pallor (HP:0000980) | 1.86019312 |
| 120 | Facial cleft (HP:0002006) | 1.84340480 |
| 121 | Abnormality of the gallbladder (HP:0005264) | 1.83381113 |
| 122 | Muscle fiber splitting (HP:0003555) | 1.82022382 |
| 123 | Areflexia of lower limbs (HP:0002522) | 1.80877192 |
| 124 | Vomiting (HP:0002013) | 1.80460000 |
| 125 | Late onset (HP:0003584) | 1.80161405 |
| 126 | Proximal placement of thumb (HP:0009623) | 1.79602550 |
| 127 | Truncus arteriosus (HP:0001660) | 1.79408480 |
| 128 | Myelodysplasia (HP:0002863) | 1.79183379 |
| 129 | Abnormal trabecular bone morphology (HP:0100671) | 1.78936281 |
| 130 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.78826610 |
| 131 | Gliosis (HP:0002171) | 1.77466987 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.77444080 |
| 133 | Aplastic anemia (HP:0001915) | 1.77340536 |
| 134 | Sparse eyelashes (HP:0000653) | 1.77156110 |
| 135 | Difficulty climbing stairs (HP:0003551) | 1.76698905 |
| 136 | Increased purine levels (HP:0004368) | 1.76107721 |
| 137 | Hyperuricemia (HP:0002149) | 1.76107721 |
| 138 | Spastic diplegia (HP:0001264) | 1.76073167 |
| 139 | Medulloblastoma (HP:0002885) | 1.75043126 |
| 140 | Lipoatrophy (HP:0100578) | 1.74468586 |
| 141 | Calcaneovalgus deformity (HP:0001848) | 1.73125243 |
| 142 | Abnormality of the ileum (HP:0001549) | 1.71702103 |
| 143 | Breech presentation (HP:0001623) | 1.70957438 |
| 144 | Squamous cell carcinoma (HP:0002860) | 1.70682962 |
| 145 | Hypokinesia (HP:0002375) | 1.70459683 |
| 146 | Nonimmune hydrops fetalis (HP:0001790) | 1.69451851 |
| 147 | Septate vagina (HP:0001153) | 1.69042583 |
| 148 | Deviation of the thumb (HP:0009603) | 1.68697404 |
| 149 | Muscle stiffness (HP:0003552) | 1.68681296 |
| 150 | Nemaline bodies (HP:0003798) | 1.67126324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.16215951 |
| 2 | BCKDK | 3.82187431 |
| 3 | EIF2AK1 | 3.77895520 |
| 4 | VRK2 | 3.56515957 |
| 5 | NEK1 | 3.41224560 |
| 6 | WEE1 | 3.36635089 |
| 7 | CDC7 | 2.73123986 |
| 8 | NME2 | 2.57124052 |
| 9 | SMG1 | 2.56607150 |
| 10 | TESK2 | 2.45950296 |
| 11 | STK16 | 2.37750641 |
| 12 | NEK2 | 2.14508184 |
| 13 | TTK | 2.06154668 |
| 14 | PDK3 | 2.00170114 |
| 15 | PDK4 | 2.00170114 |
| 16 | TSSK6 | 1.91657908 |
| 17 | EIF2AK3 | 1.90351415 |
| 18 | ACVR1B | 1.88873653 |
| 19 | KDR | 1.85610374 |
| 20 | TRIB3 | 1.80955064 |
| 21 | PKN2 | 1.74659814 |
| 22 | MAP3K10 | 1.71716964 |
| 23 | MAP3K11 | 1.67528374 |
| 24 | ERN1 | 1.56269630 |
| 25 | PLK1 | 1.53225886 |
| 26 | TTN | 1.45426402 |
| 27 | NME1 | 1.41530359 |
| 28 | SRPK1 | 1.34346455 |
| 29 | PLK4 | 1.30447312 |
| 30 | TESK1 | 1.30258442 |
| 31 | RPS6KB2 | 1.28120016 |
| 32 | AURKB | 1.27413405 |
| 33 | MAPKAPK3 | 1.24803979 |
| 34 | ARAF | 1.23774700 |
| 35 | PIM2 | 1.21156020 |
| 36 | EPHA2 | 1.20950609 |
| 37 | VRK1 | 1.18762170 |
| 38 | AURKA | 1.17618764 |
| 39 | MAP3K8 | 1.17111485 |
| 40 | PAK4 | 1.16151235 |
| 41 | CDK4 | 1.13964464 |
| 42 | SCYL2 | 1.13643464 |
| 43 | ICK | 1.12376813 |
| 44 | BRSK1 | 1.12232977 |
| 45 | OBSCN | 1.09528837 |
| 46 | PDK2 | 1.09109578 |
| 47 | ATR | 1.06868018 |
| 48 | TAF1 | 1.02301481 |
| 49 | CCNB1 | 0.99274224 |
| 50 | CDK7 | 0.97800344 |
| 51 | LRRK2 | 0.96922830 |
| 52 | RPS6KA4 | 0.96216107 |
| 53 | MAP4K1 | 0.94048834 |
| 54 | STK10 | 0.92493649 |
| 55 | DAPK1 | 0.84697969 |
| 56 | BRSK2 | 0.84344438 |
| 57 | TAOK2 | 0.84167462 |
| 58 | EEF2K | 0.83942954 |
| 59 | ILK | 0.83923476 |
| 60 | DYRK3 | 0.83873892 |
| 61 | PINK1 | 0.82935053 |
| 62 | TLK1 | 0.81278000 |
| 63 | PLK3 | 0.77227285 |
| 64 | CHEK2 | 0.77015984 |
| 65 | STK4 | 0.76583272 |
| 66 | LMTK2 | 0.76433788 |
| 67 | PASK | 0.76098818 |
| 68 | MST1R | 0.75648477 |
| 69 | MAP2K3 | 0.75376406 |
| 70 | TGFBR1 | 0.74108187 |
| 71 | CHEK1 | 0.74041851 |
| 72 | STK38L | 0.73173960 |
| 73 | FLT3 | 0.73048799 |
| 74 | MST4 | 0.70161321 |
| 75 | CLK1 | 0.69650893 |
| 76 | ALK | 0.68849512 |
| 77 | LIMK1 | 0.68038961 |
| 78 | CDK19 | 0.64083843 |
| 79 | CDK8 | 0.63960705 |
| 80 | PRPF4B | 0.62550278 |
| 81 | MAPK11 | 0.60040589 |
| 82 | MAP3K5 | 0.59371603 |
| 83 | ATM | 0.59125072 |
| 84 | CSNK2A2 | 0.58427219 |
| 85 | PAK1 | 0.57981707 |
| 86 | BRAF | 0.57340250 |
| 87 | CSNK2A1 | 0.56866062 |
| 88 | CSNK1G3 | 0.56646020 |
| 89 | PRKCI | 0.54116835 |
| 90 | IRAK3 | 0.53797861 |
| 91 | ZAK | 0.53268524 |
| 92 | MYLK | 0.52390427 |
| 93 | CDK11A | 0.52313629 |
| 94 | LATS2 | 0.52289860 |
| 95 | RPS6KA5 | 0.51839080 |
| 96 | AKT2 | 0.51832216 |
| 97 | RAF1 | 0.50093504 |
| 98 | CDK2 | 0.49084432 |
| 99 | TRIM28 | 0.48987174 |
| 100 | ABL2 | 0.47941523 |
| 101 | MAPKAPK5 | 0.45842798 |
| 102 | MELK | 0.44743473 |
| 103 | CDK15 | 0.44585111 |
| 104 | CDK14 | 0.44108826 |
| 105 | ERBB4 | 0.43874298 |
| 106 | CDK18 | 0.43415952 |
| 107 | PIM1 | 0.42445211 |
| 108 | GRK6 | 0.42142360 |
| 109 | TYK2 | 0.41398678 |
| 110 | ZAP70 | 0.40607601 |
| 111 | MAP2K6 | 0.40361255 |
| 112 | PAK2 | 0.40310136 |
| 113 | CDK9 | 0.38076621 |
| 114 | NEK9 | 0.37897420 |
| 115 | MAP3K3 | 0.37785381 |
| 116 | MAP2K2 | 0.37204094 |
| 117 | PHKG2 | 0.36890600 |
| 118 | PHKG1 | 0.36890600 |
| 119 | CSNK1A1L | 0.36177596 |
| 120 | MKNK1 | 0.35750755 |
| 121 | PBK | 0.35364051 |
| 122 | EIF2AK2 | 0.34233551 |
| 123 | MTOR | 0.34056666 |
| 124 | CSNK1G1 | 0.33952023 |
| 125 | DAPK3 | 0.33757458 |
| 126 | PRKD3 | 0.32382181 |
| 127 | BLK | 0.32350053 |
| 128 | CDK12 | 0.31178570 |
| 129 | CDK1 | 0.30747569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.65787412 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.39392559 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.36423914 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.12077589 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.96998287 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.76309971 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.53548336 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.38878712 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31068375 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.26155395 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.21810210 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.21094930 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.20358950 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.20272269 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.16070104 |
| 16 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.05910601 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02594413 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.98339515 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.90019315 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88618809 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.86240262 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.76854875 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.75599803 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65744735 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63917931 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63631854 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63609908 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56314367 |
| 29 | Cell cycle_Homo sapiens_hsa04110 | 1.54894212 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52529546 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51870700 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49545461 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46713690 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38130233 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.27985003 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25958596 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24190567 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.16032150 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14596286 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10486355 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09079537 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04044009 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02880966 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01216537 |
| 45 | Purine metabolism_Homo sapiens_hsa00230 | 1.01166005 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94140901 |
| 47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93995131 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93320207 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87651959 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86705544 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86657007 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85503709 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84216769 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83320419 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81837942 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.80969703 |
| 57 | Protein export_Homo sapiens_hsa03060 | 0.79169528 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79043381 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78914119 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78559372 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77616220 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77339462 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76520271 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74076744 |
| 65 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73937685 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72649334 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68527600 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67676992 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67596984 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61471682 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61461610 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60319082 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59676854 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59481988 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57918977 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53411411 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51962258 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51419271 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49288433 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48206636 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.42943437 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.39389426 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39343476 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38421536 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38282074 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37138281 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36807008 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36741899 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34597783 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.32656810 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29591773 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29361724 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29074452 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28389122 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28287041 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27807662 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26962821 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23587745 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23300964 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.23261712 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20800022 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20544193 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20272233 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.20144741 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17458497 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17153993 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17120266 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14857585 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14242486 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.14188412 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.13998483 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.12089471 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.11012701 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.10904511 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10277584 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.08890878 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.07160319 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06986608 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04841988 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.04298589 |

